Artemisinin |
Artemisia annua L
|
Free |
N.A. |
C
max: 0.25 ± 0.08 μM; AUG0–24h: 0.132; t
1/2β: 0.38 h; CL: 63.11 ml/h |
Isacchi et al. (2011a)
|
P90G, CHOL |
136.2 ± 42.27 |
C
max: 1.11 ± 5.60 μM; AUG0–24h: 0.836; t
1/2β: 0.67 h; CL: 9.97 ml/h |
PEG2000, P90G, CHOL |
132.6 ± 8.78 |
C
max: 1.04 ± 0.01 μM; AUG0–24 h: 0.899; t
1/2β: 2.02 h; CL: 9.20 ml/h |
L-α-phosphatidylcholine, CHOL |
79 ± 5 |
IC50: 6.0 ± 1.4 μg/ml for intracellular Leishmania donovani amastigotes; IC50: 5.1 ± 0.9 μg/ml for infected macrophages |
Y. Want et al. (2017)
|
ADP109 |
Artemisinin |
Free |
N.A. |
IC50: 0.07 ± 0.01 μM to BT474 cells; IC50: 10 ± 3 μM to MDA-MB231 cells |
Zhang et al. (2013a)
|
EPC |
70 ± 20 |
IC50: 0.08 ± 0.01 μM to BT474 cells; IC50: 7 ± 2 μM to MDA-MB231 cells |
AMPm109 |
Artemisinin |
Free |
N.A. |
IC50: 1.3 ± 0.8 μM to BT474 cells; IC50: >> 100 μM to MDA-MB231 cells |
Zhang et al. (2013a)
|
EPC |
50 ± 20 |
IC50: 1.3 ± 0.4 μM to BT474 cells; IC50: >> 20 μM to MDA-MB231 cells |
Baicalin |
Scutellaria Scutellaria baicalensis Georgi
|
HSPC, CHOL, F-PEG-CHEMS |
68.4 ± 3.6 |
IC50: 58.3 ± 3.3 μg/ml to HeLa Cells |
Chen et al. (2016)
|
HSPC, CHOL, PEG-CHEMS |
70.9 ± 1.4 |
IC50: 76.1 ± 4.6 μg/ml to HeLa Cells |
HSPC, CHOL |
87.6 ± 1.6 |
IC50: 78.8 ± 4.2 μg/ml to HeLa Cells |
Free |
N.A. |
IC50: 64.6 ± 3.8 μg/ml to HeLa Cells |
BDMC |
Turmeric
|
D-α-tocopherol polyethylene glycol 1000 succinate (TPGS or vitamin E TPGS), CHOL, mixlecithin |
75.98 ± 5.46 |
Effective analgesic activity due to prolonged latency time, and the significantly decreased level of uric acid |
Wang et al. (2021)
|
Betulinic acid |
White birch
|
Egg phosphatidylcholine, egg phosphatidylglycerol |
1000–1500 |
Efficiently inhibited human colon and lung tumors in nude mice |
Mullauer et al. (2011)
|
Borneol |
Dryobalanops aromatica Gaertn f., Blumea balsamifera DC
|
Phospholipid, CHOL |
167.1 |
BO upregulates drug effect and synergistically help the BA to promote the recovery of the brain by inhibiting neuronal cell damage and apoptosis |
Zhang et al. (2020)
|
Breviscapine |
Erigeron breviscapus
|
HSPC: CHOL, Pluronic P85 |
118.8 ± 4.9 |
Significantly increased absorption in Caco-2 cells and oral bioavailability in rats |
Zhou et al. (2014)
|
PC, PG, CHOL, triolein or tricaprylin |
17,900 |
bre-MVL significantly prolonged the retention both in vitro and in vivo compared with those of bre-TL. |
Zhong et al. (2005)
|
PC, CHOL |
540 |
BP |
Angelica sinensis
|
LPPC |
200–280 |
Liposomal BP showed higher cytotoxicity to B16/F10 melanoma cells than free BP by arresting cell cycle at G0/G1 phase |
Gao et al. (2018)
|
Camptothecin (CPT) |
Oriental tree, amptotheca acuminata
|
Single/two/three components of EPC, DOTAP, DPPG, DLPC, DMPG, DOPC, DOPE, DMPE-DTPA, DPPC, DMPC, CHOL |
30–35 |
Liposomal CPT improved the circulated time in mouse, compared with free CPT. |
Flaten et al. (2013)
|
Chlorophyll |
Chimonanthus salicifolius
|
Soybean lecithin, CHOL |
21.7 ± 6.0 |
Significantly improved the water solubility of lipophilic chlorophyll and its NIR fluorescence |
Chu et al. (2012)
|
Curcumin |
Turmeric
|
Free |
N.A. |
EC50: 1.9 and 1.5 μM to colon and lung cancer cells, respectively |
Feng et al. (2017)
|
EggPC, CHOL, DSPE-PEG |
∼420 |
EC50: 0.96 and 0.90 μM to colon and lung cancer cells, respectively |
EggPC, CHOL, DSPE-PEG (βCD-C) |
∼420 |
EC50: 3.25 and 2.9 μM to colon and lung cancer cells, respectively |
Curcumol |
Rhizoma zedoariae
|
Yolk lecithin, CHOL |
<200 nm |
Gal-s modified liposome enhanced the targeted delivery and treatment to liver cancer cells |
Li et al. (2018a)
|
Daunorubicin |
Streptomyces peucetius
|
DSPC, CHOL |
45 |
Improved plasma half life and uptake by tumor |
O'Byrne et al. (2002)
|
Docetaxel |
Glycyrrhiza glabra L. (licorice)
|
Soybean phospholipids, CHOL |
∼90 nm |
GA-modified liposomes enhanced hepatocytes-target cellular uptake by receptor-mediated endocytosis |
Li et al. (2012a)
|
Doxorubicin |
Streptomyces peucetius
|
HSPC, CHOL, MPEG-DSPE |
<100 |
AIDS-related Kaposi’s sarcoma; ovarian cancer resistant to paclitaxel and platinum |
Waterhouse et al. (2001)
|
EPS |
Epimedium
|
Soybean phospholipid, CHOL, tocopherol |
200 |
The liposomal EPS significantly improved the immune response to Newcastle disease vaccine |
Gao et al. (2012)
|
Ganoderic acid |
Lucid ganoderma
|
P90G |
150–180 |
Liposomal ganoderic acid has shown better antitumor effects by inhibiting various signaling pathways |
Rahman et al. (2019)
|
Ginsenoside |
ginseng
|
EYPC, CHOL |
60.54 ± 1.78 |
The three ginsenoside-modifications enhanced the cellular uptake mediated by GLUT carriers |
Hong et al. (2019)
|
52.02 ± 1.42 |
99.02 ± 2.55 |
Hirudin |
Hirudo spp
|
DSPC, BC |
191.49 ± 3.67 |
Inhibited the expression of VEGF and TGF-β1 in the rat kidneys |
Wang et al. (2019)
|
Honokiol |
Magnolia species
|
PC, cholesterol, PEG4000 |
130 ± 20 |
Liposomal honokiol significantly suppressed Lewis lung carcinoma overexpressing VEGF-D by inhibiting the tumor-associated lymphangiogenesis and metastasis |
Wen et al. (2009)
|
Idarubicin |
— |
DSPC, DSPE-PEG2000 |
100 ± 30 |
Enhanced the circulation longevity of idarubicin to improve antitumor activity |
Dos Santos et al. (2005)
|
Juglone |
Juglans mandshurica
|
DPPC, CHOL |
187 ± 12 |
The temperature-sensitive liposomes significantly inhibited HepG2 cell growth and proliferation upon exposed to hyperthermia |
Zhao et al. (2016)
|
220 ± 32 |
LBP |
L. barbarum
|
Soybean phospholipids, CHOL |
121.5 ± 0.2 |
The LBPL-OVA vaccine formulation enhanced immune responses |
Bo et al. (2017)
|
121.13 ± 0.37 |
Matrine |
Sophora flavescens
|
HSPC, CHOL, DSPE-mPEG2000, DSPE-PEG-MAL, cRGD-SH |
97.59 ± 1.93 |
RGD-M-LCL significantly improved the tumor-specificity and suppressed the proliferation of Bcap-37, HT-29 and A375 cells, compared with matrine alone |
Liu et al. (2010)
|
Morphine |
Papaver somniferum
|
HSPC, mPEG-DSPE, CHOL |
120.45 ± 10.53 |
Prolong analgesic effect and reduce drug addiction |
Gómez-Murcia et al. (2019)
|
OP |
Ophiopogonis japonicus
|
Soybean phospholipid, CHOL |
245.3 |
Liposomes significantly improved the immune-enhancing activity of OP on Kupffer cells |
Fan et al. (2014)
|
Soybean phospholipid, CHOL |
245.3 |
Liposomes significantly improved the immune-enhancing activity of OP against Newcastle disease virus on chicken |
Fan et al. (2015)
|
Soybean phospholipid, CHOL |
245.3 |
Liposomal OP significantly activated mouse peritoneal macrophages |
Sun et al. (2016)
|
Soybean phospholipid, CHOL |
245.3 |
Liposomal OP significantly enhanced the antioxidative and immunoregulatory activities of OP in ICR mice |
Fan et al. (2016)
|
Paclitaxel |
Taxus chinensis
|
Free |
N.A. |
IC50: 42.38 ± 2.4 and 14.71 ± 1.37 nmol/L to SKOV-3 cells and HUVECs, respectively |
Fu et al. (2019a)
|
DPPC, DSPG, MPPC, DSPE-PEG |
80.2 ± 3.9 |
IC50: 31.19 ± 2.02 and 11.51 ± 1.13 nmol/L to SKOV-3 cells and HUVECs, respectively |
DPPC, DSPG, MPPC, DSPE-PEG, DSPE-PEG-K237 |
88.3 ± 4.7 |
IC50: 13.61 ± 1.81 and 5.54 ± 0.95 nmol/L to SKOV-3 cells and HUVECs, respectively |
DSPE-PEG2000-Tn, DPPC |
74 ± 0.36 |
IC50: 1.93 nM to HepG-2 cells |
Li et al. (2021a)
|
Parthenolide |
Tanacetum parthenium
|
SPC |
118.6 ± 0.2 |
PTL-Lips enhanced the antitumor efficacy |
Gao et al. (2020a)
|
PPa |
Terrestrial and marine plants, insect fluid |
DPPC, CHOL, DSPE-mPEG5k
|
100 |
Significantly improved the water solubility, prolong blood circulation and the bio-distribution in mice |
Zhou et al. (2019)
|
PpIX |
Living cells |
PC |
124 ± 0.85 |
IC50: 0.53 ± 0.19 µM to Hela cells |
Przybylo et al. (2016)
|
RGP |
R. glutinosa
|
Soybean phospholipid, CHOL, Tween-80 |
170.83 ± 2.08 |
The positive modulation effects on dendritic cells |
Huang et al. (2016)
|
193.57 ± 1.89 |
Resveratrol |
Polygonum cuspidatum decoction pieces
|
Soybean lecithin, CHOL |
146–585 |
Liposomal resveratrol showed neuroprotective effects on mitochondria in substantia nigra cells of Parkinsonized rats |
Chen et al. (2021)
|
Sal B |
Salvia miltiorrhiza Bge
|
PEG2000(18:0/18:0), P90G, CHOL |
140.0 ± 6.5 |
The PEGylated liposome improved the antihyperalgesic effect by prolonged time |
Isacchi et al. (2011b)
|
Topotecan |
Synthetic analog of camptothecin |
Sphingomyelin, CHOL |
100 ± 20 |
The formulation enhanced the half-life in plasma |
Chernov et al. (2017)
|
Triptolide |
Tripterygium wilfordii
|
TRX-20, HSPC, PEG5000-PE |
117.9 ± 1.4 |
Significantly improved the anti-inflammatory effects in membranous nephropathic model |
Yuan et al. (2017)
|
Vincristine |
Catha-ranthus roseus
|
DSPC, CHOL |
100 |
Prolonged retention time dramatically improved the therapeutic effects on mice bearing P388 murine leukemia |
Boman et al. (1994)
|
Wogonin |
Scutellaria baicalensis Georgi
|
Free |
NA |
IC50: 16.248 mg ml−1 to HepG2 cells |
Tian et al. (2014)
|
Soybean phospholipids, CHOL |
87.4 ± 4.8 |
IC50: 3.344 mg ml−1 to HepG2 cells |
Soybean phospholipids, CHOL, 18-GA-Suc |
90.5 ± 2.2 |
IC50: 2.292 mg ml−1 to HepG2 cells |